|Articles|June 23, 2022
How Freeze-Thaw Processes Can Be Used for the Commercialization of Cell and Gene Therapy
Author(s)Entegris
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How New ADC Modalities Backed by Samsung Could Shape Solid Tumor Treatment
2
Industry Experts Probe CNPV Impacts: Part II
3
What a $2 Billion Maryland Expansion Means for the Future of Biologics Production
4
METHONOVA™: Enhancing Cell Culture Growth and Productivity with High Purity Methylcellulose
5
